BioCentury | Jul 11, 2020
Management Tracks

Andrews joins Akcea as CMO; plus changes at Strongbridge, Abeona, Lyra, Kronos and more

...will become CMO, succeeding Harold Fricke. Before joining the immuno-oncology company, Sachse was CSO of Neovii Pharmaceuticals AG...
BioCentury | Jul 20, 2018
Company News

Mundipharma gains rights to develop and commercialize Grafalon in China and Japan

...a polyclonal antibody preparation for T lymphocyte suppression. The companies did not respond to inquiries. Neovii Pharmaceuticals AG...
...Rapperswil, Switzerland Mundipharma International Ltd., Dublin, Ireland Business: Autoimmune Shannon Lehnbeuter Grafalon (Brand), ATG-Fresenius S (Other) Mundipharma International Ltd. Neovii Pharmaceuticals AG Graft-versus-host...
BioCentury | Jul 6, 2018
Company News

Management tracks: Goldman Sachs, Acceleron

...the Lilly Diabetes unit of Eli Lilly and Co. (NYSE:LLY). Transplantation and rare disease company Neovii Pharmaceuticals AG...
BioCentury | Sep 25, 2017
Company News

Management tracks: TapImmune, Camel-IDS, Arvinas

...to president and CEO from CSO and president of R&D. Transplantation and rare disease company Neovii Pharmaceuticals AG...
BioCentury | Sep 19, 2016
Company News

Regeneron, Neovii Pharmaceuticals deal

...organization and competitive pressures (see BioCentury, Nov. 5, 2012). Regeneron Pharmaceuticals Inc. (NASDAQ:REGN), Tarrytown, N.Y. Neovii Pharmaceuticals AG...
Items per page:
1 - 5 of 5
BioCentury | Jul 11, 2020
Management Tracks

Andrews joins Akcea as CMO; plus changes at Strongbridge, Abeona, Lyra, Kronos and more

...will become CMO, succeeding Harold Fricke. Before joining the immuno-oncology company, Sachse was CSO of Neovii Pharmaceuticals AG...
BioCentury | Jul 20, 2018
Company News

Mundipharma gains rights to develop and commercialize Grafalon in China and Japan

...a polyclonal antibody preparation for T lymphocyte suppression. The companies did not respond to inquiries. Neovii Pharmaceuticals AG...
...Rapperswil, Switzerland Mundipharma International Ltd., Dublin, Ireland Business: Autoimmune Shannon Lehnbeuter Grafalon (Brand), ATG-Fresenius S (Other) Mundipharma International Ltd. Neovii Pharmaceuticals AG Graft-versus-host...
BioCentury | Jul 6, 2018
Company News

Management tracks: Goldman Sachs, Acceleron

...the Lilly Diabetes unit of Eli Lilly and Co. (NYSE:LLY). Transplantation and rare disease company Neovii Pharmaceuticals AG...
BioCentury | Sep 25, 2017
Company News

Management tracks: TapImmune, Camel-IDS, Arvinas

...to president and CEO from CSO and president of R&D. Transplantation and rare disease company Neovii Pharmaceuticals AG...
BioCentury | Sep 19, 2016
Company News

Regeneron, Neovii Pharmaceuticals deal

...organization and competitive pressures (see BioCentury, Nov. 5, 2012). Regeneron Pharmaceuticals Inc. (NASDAQ:REGN), Tarrytown, N.Y. Neovii Pharmaceuticals AG...
Items per page:
1 - 5 of 5